Brain Health Roundtable featuring NewDays
Publication
Last Updated
Table of Contents
NewDays Featured in D Magazine's Brain Health Roundtable
NewDays Co-Founder & CEO Dr. Babak Parviz and Head of NewDays Clinic Dr. Daniel Fenton were recently chatted with D Magazine in support of their March Brain Health issue. They joined a robust conversation bringing together leading voices on what's new and what's next in cognitive care.
The roundtable tackled some of the most pressing questions facing families navigating cognitive decline today: What treatments exist beyond medication? How is AI changing the delivery of care? And why have so many proven therapies remained out of reach for so long?
Babak spoke to the pivotal moment we're in - where the science and the technology have finally converged:
"Just as cognitive therapy research reached scientific consensus, AI advances made scalable delivery possible. This isn't AI looking for a problem to solve; it's AI solving a delivery challenge that's limited these proven treatments for years."
He also addressed how rapidly the field has shifted, noting that the kind of personalized, conversational therapeutic interventions NewDays delivers were simply not buildable until recently:
"Building such systems was technologically impossible as recently as two to three years ago. This represents AI as genuine treatment delivery, not just diagnostic support."
Dr. Fenton brought the clinical perspective - cutting through the misconception that non-drug options don't exist or don't work:
"Many families hear little beyond medication, not because non-pharmacological treatments don't work, but because they were historically difficult to deliver at scale."
He also described what sustainable brain health actually looks like in practice:
"The sustainable model mirrors physical therapy: daily digital practice for consistency, paired with periodic clinician guidance for goal setting and adaptation."
Together, their contributions underscore what NewDays is built on: treatments that are clinically validated, now finally made accessible through the combination of AI and expert human oversight.
